Professur für CAR-T-Zell-Therapie

Late Non-Relapse Mortality (NRM) after Standard-of-Care (SOC) CAR-T Cell Therapy for Large B-Cell Lymphoma (LBCL): Frequency, Causes, and Risk Factors.a GLA/DRST Real World Analysis (2021) Dreger P, Schubert ML, Holtick U, Subklewe M, Von Bastian T, Ayuk FA, Wagner EM, et al. Conference contribution The CAR- Hematotox Identifies Patients at High Risk for Prolonged Neutropenia, Infectious Complications and Prolonged Hospitalization Following CD19-CART in R/R LBCL (2021) Rejeski K, Perez-Perez A, Iacoboni G, Penack O, Buecklein VL, Jentzsch L, Mougiakakos D, et al. Conference contribution More on CD19-CAR T Cells in Systemic Lupus Erythematosus (2021) Mougiakakos D, Krönke G, Schett G Journal article, Letter How does phagocytosis affect macrophages? (2021) Biedermann A, Flamann C, Mougiakakos D, Bitterer K, Leffler M, Kellner C, Peipp M, et al. Conference contribution β2-microglobulin triggers NLRP3 inflammasome activation in tumor-associated macrophages to promote multiple myeloma progression (2021) Hofbauer D, Mougiakakos D, Broggini L, Zaiss M, Büttner-Herold M, Bach C, Spriewald B, et al. Journal article CD19-targeted CAR T cells in refractory systemic lupus erythematosus (2021) Mougiakakos D, Krönke G, Völkl S, Kretschmann S, Aigner M, Kharboutli S, Böltz S, et al. Journal article Rapid and Efficient Gene Editing for Direct Transplantation of Naive Murine Cas9+ T Cells (2021) Majumder S, Jugovic I, Saul D, Bell L, Hundhausen N, Seal R, Beilhack A, et al. Journal article Thrombopoietin receptor agonists for acquired thrombocytopenia following anti-CD19 CAR-T-cell therapy: A case report (2021) Jitschin R, Kharboutli S, Stoll A, Büttner-Herold M, Schmidt D, Rösler W, Mackensen A, et al. Journal article Polatuzumab vedotin as a salvage and bridging treatment in relapsed or refractory large B-cell lymphomas (2021) Liebers N, Duell J, Fitzgerald D, Kerkhoff A, Noerenberg D, Kaebisch E, Acker F, et al. Journal article Editorial: NK-Myeloid Cell Interactions in the Tumor Microenvironment: Implications for Cancer Immunotherapy (2021) Wennerberg E, Lundqvist A, Mao Y, Mougiakakos D Journal article